Novel biomarkers and emerging therapies for sickle cell disease

John Longshore - Recent Progress in Predictive Biomarker Testing in OncologyПодробнее

Biomarkers in sickle cell diseaseПодробнее

Epigenetics in Mental HealthПодробнее

Webinar: Specific biomarkers for lysosomal storage disordersПодробнее

Novel Therapies in Hemophilia - Ashok B. Raj, M.D.Подробнее

Novel Biologic Therapies for Sickle Cell Disease ManagementПодробнее

What Are the Novel Treatments for Sickle Cell Disease?Подробнее

Novel Agents in Sickle Cell DiseaseПодробнее

From Genomics to Biomarkers: A New Landscape in Sickle Cell DiseaseПодробнее

GP Training: Novel therapies in Sickle CellПодробнее

Novel drugs for sickle cellПодробнее

Advances in the Treatment of Sickle Cell Disease: L-Glutamine, Crizanlizumab & Gene TherapyПодробнее

Treating sickle cell disease: novel therapies for old challengesПодробнее

Developing Hydroxyurea, the First FDA-Approved Therapy for Sickle Cell DiseaseПодробнее

Emerging drug targets for sickle cell diseaseПодробнее

Emerging Pharmacotherapeutic Approaches for the Management of Sickle Cell DiseaseПодробнее

Current therapeutic management strategies in sickle cell diseaseПодробнее

Sickle Cell Disease: Past, Present and FutureПодробнее

The limitations and future of precision medicine in sickle cell diseaseПодробнее

Developing a test for sickle cell diseaseПодробнее

New CRISPR-based sickle cell treatment, explainedПодробнее

Let’s Talk About Sickle Cell Disease: Perspectives, Case Challenges, and Clinical PearlsПодробнее

Riley Hospital gives books to patients with sickle cell diseaseПодробнее